Bloodstock agent David Ingordo’s extraordinary success stems from his imagination, the ability to see beyond what is in a young Thoroughbred and project what might be. “It’s like looking at LeBron James when he was in high school, maybe even junior high,” said Ingordo.
Month: November 2022
Stride Syndicate Platform Launched
Stride, a new syndicate platform for buying and selling shares in elite-level racehorses, was launched on Tuesday. Stride will purchase unraced yearlings and 2-year-old breeze-up horses in a price bracket from €25,000-€150,000 and will sell shares in syndicates of between two and six horses. The intention is to sell within 12 months of purchase and profits returned to owners.
Cillian Barry and Eugene Cosgrove, founders of SportCaller, are the Chairman and Head of Product, respectively, while veteran COO Donal Browne will handle the day-to-day business operations for a venture whose horses will initially be placed with trainer Joseph O'Brien. Stride's CEO is former Munster and Leicester rugby star Johne Murphy, who has operated Rugby & Racing and Thoroughbred Racing Syndicates, the latter also attached to the O'Brien yard.
Murphy said, “Stride is more than a responsive platform for buying and selling shares in elite-level racehorses. It's also a way for racing to reconnect, engage and retain its most vital stakeholders: passionate owners who support the sport through times good and bad. Our fractional ownership model readily articulates the merits over micro-ownership and its associated cautionary tales, and enables our members to choose a portfolio of racehorses that elevates enjoyment and mitigates downside at a challenging economic time across most sectors. Investors can now research, buy, manage, and watch their stable of syndicated Thoroughbreds at a fraction traditional ownership spends, with zero hidden costs or clawbacks. The price you pay for your share in the syndicate is the sole fee you'll ever be asked for.”
The post Stride Syndicate Platform Launched appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.
Monfort Labels Graduate Gold Trip “A Warrior” After Melbourne Cup Win
Michel Monfort, the man responsible for breeding this year's G1 Melbourne Cup hero Gold Trip (Fr) (Outstrip {GB}) (video), has described his graduate as “a warrior.”
Monfort bought Gold Trip's dam Sarvana (Fr), a daughter of Dubai Destination, before mating her with GI Breeders' Cup Juvenile Turf winner Outstrip (GB), who now stands in Brazil having spent six seasons at Dalham Hall.
The resulting foal turned out to be Gold Trip, who made €60,000 at the Arqana August Sale from the Haras de Grandcamp draft to Gerard Larrieu.
Gold Trip won a Group 2 in his native France for Fabrice Chappet and changed hands to join Ciaron Maher and David Eustace's barn in Australia after he finished third behind Broome (Ire) (Australia {GB}) in the G1 Grand Prix de Saint-Cloud last year.
But the undoubted highlight of Gold Trip's career came when he stormed to a two-length victory in Australia's most famous race and his breeder has backed him to be a continued success.
Monfort told Jour de Galop on Tuesday morning, “He could have continued to have a very good career in Europe. He's quite a warrior. Gold Trip won beautifully this morning in Australia, particularly given the weight he was carrying. It augurs well for the future.”
Back in 2020, Monfort told JDG about his approach to buying Sarvana, recalling how he overlooked her obvious flaws.
He said, “I bought Sarvana in almost a timid manner. She wasn't very expensive, but she was from a good Aga Khan family. She was by a stallion who has proven to be a good broodmare sire.
“These were the criteria upon which I was concentrating on during that time to buy a mare. I appreciated also that she had made it to the races, even though it was only one time.”
He added, “She proved that she had a good enough head on her and that she didn't have any hidden health problems. I envisioned the only start Sarvana had made and she wasn't at all defective. But the big outlets, if the horse didn't have a future in big races, didn't hesitate to turn the page.”
Sarvana was sold for €280,000 to David Redvers acting on behalf of Sheikh Fahad al Thani in the interim, but Monfort's interest in the family continues as he retained two fillies from the mare.
He added on Tuesday, “We have kept two fillies, of which Got Wind (GB) (Olympic Glory {Ire}) has earned black type at two and three. In general, I think if you use mares with solid families, you increase your chances to produce good horses.
“I also try to have mares from good stallions or good broodmare sires. With a descendant of Mr. Prospector like Sarvana, using stallions from the Danehill line was an interesting option.
“I believe very much in the outcross, like in the case of Gold Trip. It was my idea, anyway. The fact of carrying a different blood, that's one of the factors of the success of sons of Dubawi (Ire) right now in Europe. You can also point to the purchase of Wootton Bassett (GB) by Coolmore.
“You can get a Grade 1 winner by Outstrip or by Hat Trick (Jpn). I think there is still a place for passionate breeders, people looking for good crosses. Even if it is surely more and more difficult, and more and more expensive, to stay competitive. I also think that Outstrip is a horse who could have stayed in Europe. Without getting good mares, he still produced horses who pleased a lot of riders.”
The post Monfort Labels Graduate Gold Trip “A Warrior” After Melbourne Cup Win appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.
Don’t Delay: By Time Cushing’s Signs Appear, Disease Already Quite Advanced
Many horse owners are familiar with the stereotypical “Cushing's” horse – one that has a thick haircoat no matter the weather, a cresty neck, and a pendulous pot belly, even if he's dewormed regularly and fed quality feed and forage.
Unfortunately, by the time these signs are easily recognizable, the disease is already quite advanced.
There are early signs that a horse is developing pituitary pars intermedia dysfunction (PPID), but they are often missed, reports a just-published review. Close observation is key to noticing small changes, such as a horse that is drinking and urinating more than usual, or one that is lethargic or has recurrent infections.
The most common test for PPID is the basal adrenocorticotropic hormone (ACTH) concentration, but the most accurate test to identify the disease early is the thyrotropin-releasing hormone (TRH) stimulation test. Both of these tests have their shortcomings; basal ACTH concentrations can lack sensitivity, and TRH is not commercially available in many countries.
Drs. Naomi Kirkwood, Kristopher Hughes, and Allison Stewart note that the sooner a horse begins treatment for the disease, the better his quality of life. Though a horse can be diagnosed with PPID solely on clinical signs, the disease is often severe by this stage.
Horses with PPID require careful management. If the horse has foundered or has been diagnosed with insulin dysregulation, his feeding protocol must be even more regimented, avoiding feeds high in non-structural carbohydrates. This can be complicated by the fact that PPID horses often lose weight.
[Story Continues Below]
PPID horses also have a decreased immune function, so preventative health measures are imperative to their health. Treatment with pergolide mesylate is recommended. The authors note that there may be a correlation between low vitamin B12 and PPID, but further research is needed.
The research team stresses that early disease detection is imperative. They recommend that future studies focus on improving the accuracy of diagnosis; long-term response to pergolide should also be studied.
Read more at HorseTalk.
The post Don’t Delay: By Time Cushing’s Signs Appear, Disease Already Quite Advanced appeared first on Horse Racing News | Paulick Report.
